small molecule

SOLODYN

MINOCYCLINE HYDROCHLORIDE

Loss of exclusivityMarch 2027latest FDA-listed patent expiry
CompanyBAUSCH HEALTH US LLC

Drug detail

Brand nameSOLODYN
Active ingredientMINOCYCLINE HYDROCHLORIDE
StrengthEQ 55MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2010
Marketing statusDISCN

Listed patents

PatentExpiresType
7919483March 2027use U-1078

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

SOLODYN patent cliff — loss of exclusivity March 2027 | CliffBio